March 4, 2013 - Atlanta, GA. The U.S. Women and PrEP Working Group, a coalition of more than 50 women from leading AIDS and women’s health organizations, today called on US government agencies to coordinate a national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at risk of HIV infection. Continue Reading...
Do you get our newsletter?
Sign up for our monthly Newsletter and get the latest info in your inbox.
Entrevistamos Arianna Lint, miembro del Consejo Asesor de la Comunidad y Una Chica Como Yo blogger, para nuestra "Enfoque: Mujeres Creando Diferencia" serie.
Learn about peripheral neuropathy – what it is, what puts people at risk of developing it, its signs and symptoms, and available treatments.